A Study of ENMD-2076 in Ovarian Clear Cell Cancers
NCT01914510
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Clear Cell Carcinoma
Interventions
DRUG:
ENMD-2076
Sponsor
University Health Network, Toronto